Methamphetamine Dependence
54
1
1
39
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
24 trials with published results (44%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
11.1%
6 terminated out of 54 trials
86.7%
+0.2% vs benchmark
17%
9 trials in Phase 3/4
62%
24 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (54)
rTMS for Stimulant Use Disorders
Risk and Protective Factors for Rural Methamphetamine Dependence
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Smoking-Cessation and Stimulant Treatment (S-CAST)
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving
Modafinil vs Placebo for the Treatment of Methamphetamine Dependence
Pilot Study of Entacapone for Methamphetamine Abuse
Effects of Modafinil in Methamphetamine Dependence
Trial of Ibudilast for Methamphetamine Dependence
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
Intensive Motivational Interviewing for Methamphetamine Dependence
Buspirone as a Candidate Medication for Methamphetamine Abuse
Varenicline for Methamphetamine Dependence
Modafinil for Methamphetamine Dependence
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence
Safety Assessment of Atomoxetine With MA IV Administration